Editorial on “Esophagectomy with lymphadenectomy guided by fluorescence imaging with indocyanine green in esophageal cancer”

Esophageal cancer is one of the gastrointestinal cancers with the greatest incidence over the past years and is the eighth most common cancer worldwide, affecting more than 450 000 people per year1. Its treatment and prognosis depend on tumor stage, location, histological type, nutritional status and presence of comorbidities2. Although there have been significant advances in the field of oncology in recent years, esophagectomy with lymph node clearance remains the main curative treatment. Total esophagectomy with two-field or three-field lymphadenectomy plays a very important role in the locoregional control of the disease. In recent years, the technological advances and the development of minimally invasive surgical techniques have significantly reduced morbidity and mortality.